Yili Pharmaceutical Co., Ltd. (formerly known as Guangdong Yili Group Pharmaceutical Co., Ltd.) is a high-tech pharmaceutical enterprise with pharmaceutical research and development, pharmaceutical production and sales as its core business.

The company's predecessor, Guangdong Yili Pharmaceutical Co., Ltd., was established in 2002. In 2006, Guangdong Yili Pharmaceutical Co., Ltd. was changed to Guangdong Yili Pharmaceutical Group Co., Ltd., and in 2008, it established Guangdong Yili Pharmaceutical Co., Ltd., which inherited Guangdong Yili Pharmaceutical Co., Ltd. as a whole. Li Pharmaceutical Group Co., Ltd.'s pharmaceutical business. Since its establishment, the company's business has developed rapidly year by year, and its comprehensive strength has been continuously improved. It has successively won honorary titles such as "High-tech Enterprise" and "Contract-abiding and Credit-oriented Enterprise".

The company has 4 wholly-owned subsidiaries and 2 holding subsidiaries. Its holding subsidiary Guangdong Yililuo Customized Pharmaceutical Co., Ltd. is a modern production base with Chinese patent medicine products as the core, covering an area of ​​more than 400 mu. There are advanced production lines such as tablets, oral liquids, capsules, granules, and traditional Chinese medicine extraction. The company's production base in Sihui City covers an area of ​​more than 160 acres, mainly producing Chinese medicine preparation products such as tablets, granules, oral liquids, liniments, capsules, etc.

The company and its subsidiaries have a total of 187 drug production approval numbers, including some exclusive products and national traditional Chinese medicine protected varieties.

During the production and operation process, the company has continuously carried out technical development activities such as technological innovation and problem-solving problems, and actively strengthened close cooperation with colleges, research institutes and other units. It has completed a number of research and development work, and some research and development results have been It has been applied in the project, some have been filed and have obtained national patents.

The company keeps up with the development trend of modern traditional Chinese medicine, gradually forms a green circular economy industrial chain, and is committed to building a "green pharmaceutical" enterprise to ensure the innovative development of the enterprise.

The company's future development focuses on the blue ocean of health, actively creates an upgraded version of "green pharmaceuticals", implements the "Yili Pharmaceutical" brand strategy, strengthens and expands the enterprise, and realizes the sustainable development of the enterprise, and promotes national medicine and the country to implement the healthy China strategy. Make a contribution.